Kinsale Capital Group, Inc. Bristol Myers Squibb CO Transaction History
Kinsale Capital Group, Inc.
- $546 Million
- Q3 2025
A detailed history of Kinsale Capital Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kinsale Capital Group, Inc. holds 168,640 shares of BMY stock, worth $7.89 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
168,640
Previous 149,777
12.59%
Holding current value
$7.89 Million
Previous $6.93 Million
9.69%
% of portfolio
1.39%
Previous 1.43%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...